SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Statement On Deviation Or Variation In The Use Of Proceeds Of Preferential Issue
As attached.08-08-2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per letter attatchedSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Intimation for Unaudited Results And Funds Raising
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 ,inter alia, to consider and approve the Unaudited financial Results for the quarter ended June 30, 2022 and to evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals.SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per letter attachedSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per letter attachedSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As per letter attachedSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per letter attachedSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Closure of Trading Window
As per letter attached